App is temporarily unavailable
Description
N/A
Screenshots
Loading...
Please wait..
康药多 FAQ
-
Is 康药多 free?
Yes, 康药多 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 康药多 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 康药多 cost?
康药多 is free.
-
What is 康药多 revenue?
To get estimated revenue of 康药多 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Belarus yet.
Ratings History
康药多 Reviews
App doesn't have any reviews yet
康药多 Installs
Last 30 days
康药多 Revenue
Last 30 days康药多 Revenue and Downloads
Gain valuable insights into 康药多 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Unknown
- Languages
- English, Chinese
- Recent release
- 3.1.1 (1 year ago )
- Released on
- Jul 31, 2020 (4 years ago )
- Also available in
- China , United Kingdom , France , Russia , Hong Kong SAR China , Ireland , India , Italy , Japan , Kuwait , Poland , Pakistan , Mexico , Nigeria , Norway , New Zealand , Peru , Philippines , Spain , Egypt , Sweden , Algeria , Australia , Azerbaijan , Singapore , Denmark , Germany , Türkiye , Taiwan , Chile , Ukraine , Canada , United States , Argentina , Vietnam , Portugal , Romania , South Africa , Lebanon , Kazakhstan , Indonesia , Hungary , Greece , Ecuador , Dominican Republic , Czechia , Colombia , Switzerland , Belarus , Belgium , Austria
- Last Updated
- 1 year ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.